Herbert Smith Freehills has advised Morgan Stanley and CICC on the matter while O’Melveny & Myers and Maples and Calder represented Acotec Scientific Holdings Limited. The...
Acotec Scientific Holdings Limited’s HK$1.529 Billion Hong Kong Initial Public Offering
Shanghai HeartCare Medial Technology Corporation Limited’s HK$1.13 Billion Hong Kong Initial Public Offering
Herbert Smith Freehills has advised Shanghai HeartCare Medial Technology Corporation Limited (06609.HK) on its mainboard listing on the Stock Exchange of Hong Kong. O’Melveny & Myers...
Brii Biosciences’ US$318 Million Hong Kong IPO
O’Melveny & Myers and Maples and Calder advised Brii Biosciences Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley and UBS. Brii Biosciences Limited...
UNQ Holdings Limited’s US$46.86 Million Initial Public Offering
Herbert Smith Freehills has advised CICC on the deal. UNQ Holdings Limited (02177.HK) has been listed on the Stock Exchange of Hong Kong. CICC acted as sole...
CARsgen Therapeutics Holdings Limited’s Listing on the Stock Exchange of Hong Kong
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....